|
Sandra Degen, PhD, vice president for research, is also a professor of pediatrics and associate chair for academic affairs in the UC College of Medicine’s Department of Pediatrics.
After receiving a PhD in biochemistry from the University of Washington, Degen completed two years of postdoctoral work at the Friedrich Miescher Institute, Basel, Switzerland. She joined the faculty and staff of the College of Medicine and Cincinnati Children's Research Foundation in 1985.
A Pew Scholar in the biomedical sciences, Degen's scientific interests include the biological function of the blood coagulation agent prothrombin, as well as a protein identified in her lab that is involved in growth control. She has enjoyed continuous grant support since she received her first academic position. Degen holds three patents for her discoveries.
Her many honors include an Established Investigatorship from the American Heart Association, membership of the Hematology II Study Section at the National Institutes of Health, and participation in the Executive Leadership in Academic Medicine Program. She was also awarded the 2005 Special Recognition Award in Thrombosis from the American Heart Association.
Degen currently serves on the board of directors for BIO/START, a Cincinnati biotech business incubator, and TechSolve, a Cincinnati-based company that works to enhance the competitiveness of manufacturing and technology businesses. She is a member of BioOhio, Oak Ridge Associated Universities (ORAU) and serves on the Council on Research Policy and Graduate Education of the National Association of State Universities and Land-Grant Colleges (NASULGC).
|
|
|
